X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Abbott India with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs TEVA PHARMA (Israel) - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ABBOTT INDIA   TEVA PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-18
TEVA PHARMA
Dec-13
ABBOTT INDIA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs6,1102,901-   
Low Rs3,9962,520-   
Sales per share (Unadj.) Rs1,552.21,664.6-  
Earnings per share (Unadj.) Rs188.8104.0-  
Cash flow per share (Unadj.) Rs196.4238.5-  
Dividends per share (Unadj.) Rs55.0091.03-  
Dividend yield (eoy) %1.13.4 32.4%  
Book value per share (Unadj.) Rs796.61,849.1-  
Shares outstanding (eoy) m21.25848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.31.6 200.0%   
Avg P/E ratio x26.826.1 102.7%  
P/CF ratio (eoy) x25.711.4 226.4%  
Price / Book Value ratio x6.31.5 432.8%  
Dividend payout %29.187.5 33.3%   
Avg Mkt Cap Rs m107,3762,298,173 4.7%   
No. of employees `0003.344.9 7.4%   
Total wages/salary Rs m3,9370-   
Avg. sales/employee Rs Th9,929.331,407.7 31.6%   
Avg. wages/employee Rs Th1,185.10-   
Avg. net profit/employee Rs Th1,207.71,962.0 61.6%   
INCOME DATA
Net Sales Rs m32,9851,411,620 2.3%  
Other income Rs m1,1700-   
Total revenues Rs m34,1551,411,620 2.4%   
Gross profit Rs m5,245386,573 1.4%  
Depreciation Rs m162114,103 0.1%   
Interest Rs m3827,727 0.1%   
Profit before tax Rs m6,215244,744 2.5%   
Minority Interest Rs m01,112 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-160,661 0.0%   
Tax Rs m2,203-2,988 -73.7%   
Profit after tax Rs m4,01288,183 4.5%  
Gross profit margin %15.927.4 58.1%  
Effective tax rate %35.4-1.2 -2,903.0%   
Net profit margin %12.26.2 194.7%  
BALANCE SHEET DATA
Current assets Rs m22,655953,403 2.4%   
Current liabilities Rs m6,681831,448 0.8%   
Net working cap to sales %48.48.6 560.5%  
Current ratio x3.41.1 295.7%  
Inventory Days Days6591 71.3%  
Debtors Days Days2996 30.4%  
Net fixed assets Rs m835461,066 0.2%   
Share capital Rs m2133,475 6.1%   
"Free" reserves Rs m16,7150-   
Net worth Rs m16,9281,568,042 1.1%   
Long term debt Rs m0721,793 0.0%   
Total assets Rs m24,1623,226,004 0.7%  
Interest coverage x163.79.8 1,665.7%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x1.40.4 312.0%   
Return on assets %16.83.6 466.6%  
Return on equity %23.75.6 421.5%  
Return on capital %36.94.9 749.1%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-3,4380-   
CASH FLOW
From Operations Rs m1,527224,939 0.7%  
From Investments Rs m-2,148-79,705 2.7%  
From Financial Activity Rs m-1,024-269,830 0.4%  
Net Cashflow Rs m-1,646-124,596 1.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 69.49 Rs / USD

Compare ABBOTT INDIA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare ABBOTT INDIA With: FULFORD INDIA  CADILA HEALTHCARE  AJANTA PHARMA  ELDER PHARMA  JUBILANT LIFE SCIENCES  



Today's Market

Modi's Victory Creates Sensex History; Ache Din Ahead?(Podcast)

Throughout the week, one slogan that took over the market and country as a whole was, Ab ki baar phir Modi Sarkar.

Related Views On News

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (2QFY19); Net Profit Up 0.1% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 0.1% YoY). Sales on the other hand came in at Rs 10 bn (up 5.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

3 Stocks to Bet on to Become a 'Dividend Millionaire'(Profit Hunter)

May 14, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

Indian Steel: The Perfect Multibagger Opportunity(Profit Hunter)

May 17, 2019

A structurally strong Indian Steel Industry will help India achieve 8%+ GDP growth in the coming years.

My Top 7 Stocks to Buy as Modi Returns to Power(The 5 Minute Wrapup)

May 23, 2019

The Modi government is all set to come back to power. With a stable government at the centre, how should you play the stock market?

What Makes TVS Srichakra and CCL Products a Cut Above the Rest?(The 5 Minute Wrapup)

May 17, 2019

Despite the commodity nature of their businesses, these two stocks have rewarded shareholders well.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


May 24, 2019 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 5-YR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS